---
title: "JINLING PHARM.: Director Zhang Qunhong resigns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239062284.md"
description: "JINLING PHARM. announced that the company's board of directors received the resignation letter from Mr. Zhang Qunhong, who resigned from his positions as a director of the company and a member of the board nomination committee and the board compensation and assessment committee due to work requirements. After his resignation, Mr. Zhang Qunhong will no longer hold any position in the company"
datetime: "2025-05-07T07:44:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239062284.md)
  - [en](https://longbridge.com/en/news/239062284.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239062284.md)
---

# JINLING PHARM.: Director Zhang Qunhong resigns

JINLING PHARM. announced that the company's board of directors received the resignation letter from Mr. Zhang Qunhong, who resigned from his positions as a director of the company and a member of the board nomination committee and the board compensation and assessment committee due to work requirements. After his resignation, Mr. Zhang Qunhong will no longer hold any position in the company

### Related Stocks

- [000919.CN](https://longbridge.com/en/quote/000919.CN.md)

## Related News & Research

- [MMK: Fit-For-Future programme drove resilient earnings and margin stability despite market softness](https://longbridge.com/en/news/296440411.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [09:02 ETEvolved By Nature's Peptide Platform Used in FDA-Cleared Prescription Therapy for the Management of Atopic Dermatitis](https://longbridge.com/en/news/296496101.md)